CAPTRUST Financial Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $110M | Buy |
487,861
+7,803
| +2% | +$1.94M | 0.19% | 100 |
|
|
2025
Q4 | $116M | Sell |
480,058
-57,565
| -11% | -$14.7M | 0.22% | 89 |
|
|
2025
Q3 | $147M | Buy |
537,623
+27,565
| +5% | +$7.53M | 0.3% | 65 |
|
|
2025
Q2 | $132M | Buy |
510,058
+29,729
| +6% | +$7.09M | 0.29% | 69 |
|
|
2025
Q1 | $108M | Buy |
480,329
+36,989
| +8% | +$8.64M | 0.27% | 74 |
|
|
2024
Q4 | $101M | Buy |
443,340
+394,803
| +813% | +$95.1M | 0.29% | 71 |
|
|
2024
Q3 | $11.8M | Buy |
48,537
+43,689
| +901% | +$9.76M | 0.04% | 346 |
|
|
2024
Q2 | $928K | Buy |
4,848
+556
| +13% | +$113K | ﹤0.01% | 1183 |
|
|
2024
Q1 | $850K | Sell |
4,292
-663
| -13% | -$121K | ﹤0.01% | 1209 |
|
|
2023
Q4 | $852K | Buy |
4,955
+859
| +21% | +$132K | ﹤0.01% | 1375 |
|
|
2023
Q3 | $606K | Sell |
4,096
-1,775
| -30% | -$321K | ﹤0.01% | 1520 |
|
|
2023
Q2 | $1.28M | Buy |
5,871
+135
| +2% | +$30.1K | 0.01% | 1052 |
|
|
2023
Q1 | $1.26M | Sell |
5,736
-1,370
| -19% | -$297K | 0.01% | 921 |
|
|
2022
Q4 | $1.48M | Sell |
7,106
-1,125
| -14% | -$247K | 0.01% | 815 |
|
|
2022
Q3 | $1.8M | Sell |
8,231
-558
| -6% | -$127K | 0.01% | 712 |
|
|
2022
Q2 | $1.84M | Buy |
8,789
+694
| +9% | +$148K | 0.01% | 620 |
|
|
2022
Q1 | $1.96M | Sell |
8,095
-39
| -0.5% | -$9.43K | 0.01% | 601 |
|
|
2021
Q4 | $2.12M | Sell |
8,134
-536
| -6% | -$139K | 0.01% | 552 |
|
|
2021
Q3 | $2.29M | Sell |
8,670
-702
| -7% | -$192K | 0.02% | 496 |
|
|
2021
Q2 | $2.31M | Sell |
9,372
-1,034
| -10% | -$217K | 0.02% | 461 |
|
|
2021
Q1 | $2.02M | Buy |
10,406
+1,986
| +24% | +$398K | 0.02% | 466 |
|
|
2020
Q4 | $1.79M | Buy |
8,420
+1,725
| +26% | +$344K | 0.02% | 434 |
|
|
2020
Q3 | $1.14M | Buy |
6,695
+1,962
| +41% | +$362K | 0.02% | 473 |
|
|
2020
Q2 | $903K | Buy |
4,733
+848
| +22% | +$139K | 0.01% | 533 |
|
|
2020
Q1 | $553K | Sell |
3,885
-96
| -2% | -$15.3K | 0.01% | 565 |
|
|
2019
Q4 | $621K | Buy |
3,981
+1,931
| +94% | +$278K | 0.01% | 617 |
|
|
2019
Q3 | $277K | Sell |
2,050
-34
| -2% | -$4.46K | 0.01% | 506 |
|
|
2019
Q2 | $254K | Buy |
2,084
+35
| +2% | +$3.88K | 0.01% | 515 |
|
|
2019
Q1 | $213K | Buy |
2,049
+2,024
| +8,096% | +$209K | 0.01% | 507 |
|
|
2018
Q4 | $3K | Buy |
25
+24
| +2,400% | +$2.57K | ﹤0.01% | 1441 |
|
|
2018
Q3 | $0 | Sell |
1
-457
| -100% | -$50.1K | ﹤0.01% | 1679 |
|
|
2018
Q2 | $47K | Buy |
458
+107
| +30% | +$10.8K | ﹤0.01% | 695 |
|
|
2018
Q1 | $34K | Buy |
351
+109
| +45% | +$10.3K | ﹤0.01% | 699 |
|
|
2017
Q4 | $20K | Buy |
+242
| New | +$20K | ﹤0.01% | 791 |
|
Other funds holding RMD
VCM
VPM
DAM
CAPTRUST Financial Advisors's RMD Position: Q1 2026 in Review
CAPTRUST Financial Advisors increased its ResMed (RMD) stake by 1.6% in Q1 2026, buying an estimated $1.94M and bringing the position to 487,861 shares worth $110M. The position accounts for 0.19% of the portfolio, ranked #100.
CAPTRUST Financial Advisors first reported a position in RMD in Q4 2017 and has held it in 34 quarters since. The position peaked at $147M in Q3 2025. 940 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- CAPTRUST Financial Advisors held 487,861 shares of ResMed worth $110M as of Q1 2026.
- CAPTRUST Financial Advisors bought 7,803 ResMed shares in Q1 2026, an estimated $1.94M.
- ResMed made up 0.19% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #100 holding.
- CAPTRUST Financial Advisors first reported a position in ResMed in Q4 2017 and has held it in 34 quarters since.
- CAPTRUST Financial Advisors's ResMed position peaked at $147M in Q3 2025.
- 940 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.